Home Health & Medical Health Pharmaceuticals

Cefaclor

faceboox pinterest twitter share

Negotiable Min Order Quantity Unit

Required Quantity

Place of Origin

Payment Terms: Negotiable

Production method: Negotiable

Shipping / Lead Time: Negotiable / Negotiable

Keyword

Category: Pharmaceuticals

SEND TO SUPPLIER INQUIRY

Kyongbo Pharmaceutical Co., Ltd.

Country / Year Established: South Korea /

Business type: Others

Verified Certificate

TRADE TOWER

DUNS

Minisite Follow Company

PRODUCT DESCRIPTION COMPANY INFORMATION Related Products

Product name	Cefaclor	Certification	-
Category	Pharmaceuticals	Ingredients	-
Keyword	-	Unit Size	-
Brand name	-	Unit Weigh	-
origin		Stock	-
Supply type	-	HS code	-

Product Information

MOLECULAR FORMULA
C15H14ClN3O4S.H2O

MOLECULAR WEIGHT
385.82

CAS REGISTRY NUMBER
[70356-03-5]

Conformed to
USP, EP, JP, KP

On processing of CEP
Registration Number ( KDMF ) : 20050831-20-A-19-03

Target
Intermediate spectrum cephalosporins ; cell wall synthesis inhibitor

Therapeutic category
    Agents against pathologic organisms and parasites
     Cephalosporin antibiotics( 2nd generation )
   Acting mainly on gram-positive and gram-negative bacteria

B2B Trade

Price (FOB)	Negotiable	transportation	-
MOQ	Negotiable	Leadtime	Negotiable
Payment Options	Negotiable	Shipping time	Negotiable

Kyongbo Pharmaceutical Co., Ltd.

Minisite Heart

Country / Year Established: South Korea /

Business type: Others

TRADE TOWER

DUNS

President: Kang, Tae Won

Address: 174 Silok-ro, Asan-Si, Chungcheongnam-Do, 336-020, Korea

Product Category: Other Pharmaceutical Chemicals

No. of Total Employees: 101-500

Company introduction: ISO 9001(QMS) / 14001(EMS), GMP Certification

Kyongbo Pharmaceuical Co., Ltd. is a subsidiary company of Chong Kun Dang pharmaceutical corp. The company is a pioneer in the active pharmaceutical industry in Korea, founded in 1987, with a future-oriented outlook for fine chemistry as a promising high-tech industry for the 21st century and with the humanitarian mission to contribute to the life and health of mankind.

With its primary goal set in developing new pharmaceutical substances, the company operates under the main strategy the secure superior competitive edge by simplifying and streamlining its manufacturing procedures through technological innovation and producing highly profitable raw materials for drugs.